ACEP ID:

Opioid Resources

Consensus Recommendations on the Treatment of Opioid Use Disorder in the ED

Learn More

 

Treatment & Management

 

Opioid Prescribing in the ED

Reference Materials for ED Staff

Opioid Use Disorder Resources

Patient Education Handouts

Additional Education

Free CME

Why Addiction is Not Just a “Tox” Problem

#FOAMed Podcast

Dr. Howie Mell and Dr. Rick Pescatore face-off over Suboxone

More CME

Pain Management, Palliative Care, and Addiction CME Collection

Webinar Series

Discussing Opioid Related Federal and State Regulations, and State Initiatives

Toxicology Section

National Advocacy Efforts on Opioids


ACEP Helps Get 3-Day Bupe Rule Changed to Improve Patient Care

Dec. 12, 2020 - As part of the stopgap funding bill approved by Congress in December 2020, emergency physicians will now be able to dispense up to a three-day supply of buprenorphine at one time to a patient suffering from acute withdrawal symptoms. The funding bill included the "Easy Medication Access and Treatment for Opioid Addiction Act" (Easy MAT Act), H.R. 2281, which ACEP has been working on with Congressman Dr. Raul Ruiz (D-CA) since last year. Read more

Congress Passes Opioid Package

Oct. 24, 2018 - President Trump signed a sweeping legislative package of bills to address the nation's growing opioid epidemic. Included in the package are the "Alternatives to Opioids (ALTO) in the Emergency Department Act" and the "Preventing Overdoses While in Emergency Rooms (POWER) Act," both of which ACEP developed with the sponsoring members of Congress. Read the press release.

Read more about Emergency Medicine Opioid Principles on ACEP's advocacy website.  

 

ACEP Letter of Support - "Excellence in Mental Health & Addiction Treatment Expansion Act”
HR 3931
S. 1905
October 19, 2017

ACEP-Supported Innovations Bill Sent to President
December 2016

ACEP Letter of Support for the "21st Century Cures Act"
House
Senate
November 2016

Congress Approves Comprehensive Addiction and Recovery Act
July 2016

LIVE CHAT
[ Feedback → ]